Recent research reported that single nucleotide polymorphisms (SNPs) in two genes, patatin-like phospholipase domain-containing protein 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2), increased the risk of NAFLD [17]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.